5000 hepatitis b patients to be tracked for immune clues

NCT ID NCT07137247

Recruiting now Knowledge-focused Sponsor: Nanfang Hospital, Southern Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 5000 people with chronic hepatitis B who are not on antiviral treatment, aged 1 to 80, for several years. Researchers will take blood samples every six months to track how the immune system responds to the virus as patients age. The goal is to better understand the natural course of the disease and how immunity changes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal how the immune system changes as chronic hepatitis B progresses, potentially guiding future treatments or vaccination strategies.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to emerge. Findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEP B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEP B HBV (HEPATITIS B VIRUS) HBV INFECTION

Contacts and locations

Locations

Nanfang Hospital, Southern Medical University
RECRUITING

Guangzhou, Guangdong, 510515, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.